Matches in Wikidata for { <http://www.wikidata.org/entity/Q66030267> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q66030267 description "clinical trial" @default.
- Q66030267 description "ensayu clínicu" @default.
- Q66030267 description "klinisch onderzoek" @default.
- Q66030267 description "клінічне випробування" @default.
- Q66030267 description "կլինիկական փորձարկում" @default.
- Q66030267 name "Multicenter Study Evaluating 12 Versus 24 Weeks Therapy With Peginterferon and Ribavirin for Hepatitis C Virus (HCV) Genotype 2 or 3" @default.
- Q66030267 name "Multicenter Study Evaluating 12 Versus 24 Weeks Therapy With Peginterferon and Ribavirin for Hepatitis C Virus" @default.
- Q66030267 type Item @default.
- Q66030267 label "Multicenter Study Evaluating 12 Versus 24 Weeks Therapy With Peginterferon and Ribavirin for Hepatitis C Virus (HCV) Genotype 2 or 3" @default.
- Q66030267 label "Multicenter Study Evaluating 12 Versus 24 Weeks Therapy With Peginterferon and Ribavirin for Hepatitis C Virus" @default.
- Q66030267 prefLabel "Multicenter Study Evaluating 12 Versus 24 Weeks Therapy With Peginterferon and Ribavirin for Hepatitis C Virus (HCV) Genotype 2 or 3" @default.
- Q66030267 prefLabel "Multicenter Study Evaluating 12 Versus 24 Weeks Therapy With Peginterferon and Ribavirin for Hepatitis C Virus" @default.
- Q66030267 P1050 Q66030267-0DBC5F0D-E082-49CA-B8D6-61FCB3C3297F @default.
- Q66030267 P1050 Q66030267-3149AC96-8E95-43F8-A7F1-1B2DB9376F45 @default.
- Q66030267 P1050 Q66030267-AAEBF395-64A4-4935-8383-E8EE2916FE4E @default.
- Q66030267 P1132 Q66030267-1B1D4397-D48D-42F6-917A-BA067145B206 @default.
- Q66030267 P1476 Q66030267-B3DF7242-1686-4F42-B1D6-A9C7FE759EB7 @default.
- Q66030267 P17 Q66030267-C5BB10E6-677A-426D-93D2-9252EA01397E @default.
- Q66030267 P2899 Q66030267-87279DD3-0EA1-4F47-8129-B6F6FFC73210 @default.
- Q66030267 P3098 Q66030267-267B8279-1757-40EB-97F2-EFA73D2F8EC3 @default.
- Q66030267 P31 Q66030267-87D6A7CF-E5F7-47D4-ADB5-BC57B6966A3D @default.
- Q66030267 P4844 Q66030267-F389A136-DF66-4D85-BE70-5BF85F854980 @default.
- Q66030267 P580 Q66030267-E5924799-E015-4D07-9D81-D30D7FCC7EDE @default.
- Q66030267 P6099 Q66030267-D51B85F7-4D62-49CF-B8EF-9EB958E0D824 @default.
- Q66030267 P8363 Q66030267-0763D8DB-49DA-4914-A0C4-E1E4A3B87A6D @default.
- Q66030267 P1050 Q131742 @default.
- Q66030267 P1050 Q154869 @default.
- Q66030267 P1050 Q157661 @default.
- Q66030267 P1132 "+392" @default.
- Q66030267 P1476 "A Multicenter Study Evaluating the Efficacy and Safety of 12 Weeks Versus 24 Weeks Peginterferon Alfa-2a 40KD Combination Therapy With Ribavirin in Interferon Naïve Patients With Chronic Hepatitis C Genotype 2 or 3 Infection" @default.
- Q66030267 P17 Q34 @default.
- Q66030267 P2899 "+18" @default.
- Q66030267 P3098 "NCT00143000" @default.
- Q66030267 P31 Q30612 @default.
- Q66030267 P4844 Q20817235 @default.
- Q66030267 P580 "2004-04-01T00:00:00Z" @default.
- Q66030267 P6099 Q42825046 @default.
- Q66030267 P8363 Q78089383 @default.